Similar articles

• Treatment of non-dipper hypertension with bedtime administration of valsartan.

  Hermida RC, Calvo C, Ayala DE, Fernández JR, Covelo M, Mojón A, López JE. Hermida RC, et al. J Hypertens. 2005 Oct;23(10):1913-22. doi: 10.1097/01.hjh.0000182522.21569.c5. J Hypertens. 2005. PMID: 16148616 Clinical Trial.
• VALUE in hypertension treatment.

  Berk BC, Bisognano JD. Berk BC, et al. Curr Hypertens Rep. 2004 Dec;6(6):411-3. doi: 10.1007/s11906-004-0032-6. Curr Hypertens Rep. 2004. PMID: 15527682 No abstract available.
• Pretreatment levels of plasma renin activity predict ambulatory blood pressure response to valsartan in essential hypertension.

  Minami J, Ohno E, Furukata S, Ishimitsu T, Matsuoka H. Minami J, et al. J Hum Hypertens. 2009 Oct;23(10):683-6. doi: 10.1038/jhh.2009.31. Epub 2009 Apr 16. J Hum Hypertens. 2009. PMID: 19369955 Clinical Trial. No abstract available.
• Hope in Life and Value of blood pressure control.

  Ruilope LM, Segura J. Ruilope LM, et al. J Hypertens. 2004 Dec;22(12):2265-6. doi: 10.1097/00004872-200412000-00005. J Hypertens. 2004. PMID: 15614017 Review. No abstract available.
• Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.

  Frampton JE, Scott LJ. Frampton JE, et al. Am J Cardiovasc Drugs. 2009;9(5):309-30. doi: 10.2165/11201120-000000000-00000. Am J Cardiovasc Drugs. 2009. PMID: 19791840 Review.